Primary and Secondary Chemoprevention of Malignant Melanoma.

Authors: Mounessa J, Buntinx-Krieg T, Qin R, Dunnick CA, Dellavalle RP


Am J Clin Dermatol. 2016 Dec;17(6):625-634

The incidence of malignant melanoma (MM) continues to rise in the United States. While sun protection and full body skin examinations remain the mainstay of preventative care, chemoprevention of the deadly disease has become an increasingly popular field of study. In this focused review, we discuss current findings and analyze the risks and benefits of various agents investigated for the primary and secondary chemoprevention of MM. Such agents include topical retinoids, vitamins, and supplements, Polypodium leucotomas extracts, non-steroidal anti-inflammatory agents (NSAIDs), statins, sunscreens, and field therapy with topical imiquimod for primary and secondary chemoprevention. We further identify a need for expanded high quality human research on the topic.



Read Abstract

Select your region and press submit to request this article from your local library